Fund HoldingsTYBOURNE CAPITAL MANAGEMENT (HK) LTD

Total Portfolio Value
$34.54M
Total Bought
$18.16M
Total Sold
$7.18M
Net Transaction
+$10.98M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
FORTE BIOSCIENCES INC (FBRX US)(FBRX)619,981786,647+166,6664,81110,17129.45%+5,360
TAYSHA GENE THERAPIES INC (TSHA US)(TSHA)3,700,0004,095,000+395,0005,1439,45927.39%+4,316
ALUMIS INC (ALMS US)01,399,250+1,399,25004,19812.15%+4,198
MALIBU BOATS INC (MBUU US)066,705+66,70502,0916.05%+2,091
BICYCLE THERAPEUTICS LTD-ADR (BCYC US)576,343993,743+417,4004,8936,90720.00%+2,013
ZENTALIS PHARMACEUTICALS INC (ZNTL US)961,4861,478,152+516,6661,5291,7154.96%+186
ACELYRIN INC (SLRN US)2,906,6290-2,906,6297,1790-7,179
Page 1 of 1